Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to -$281000.0.

  • Utah Medical Products' Deferred Taxes fell 43018.87% to -$281000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$583000.0, marking a year-over-year increase of 2941.89%. This contributed to the annual value of -$359000.0 for FY2024, which is 4819.62% up from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' Deferred Taxes is -$281000.0, which was down 43018.87% from -$151000.0 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Deferred Taxes ranged from a high of $230000.0 in Q2 2021 and a low of -$409000.0 during Q4 2023
  • Its 5-year average for Deferred Taxes is -$115052.6, with a median of -$144000.0 in 2022.
  • Its Deferred Taxes has fluctuated over the past 5 years, first skyrocketed by 123333.33% in 2021, then tumbled by 630000.0% in 2024.
  • Quarter analysis of 5 years shows Utah Medical Products' Deferred Taxes stood at $68000.0 in 2021, then plummeted by 88.24% to $8000.0 in 2022, then crashed by 5212.5% to -$409000.0 in 2023, then soared by 114.18% to $58000.0 in 2024, then tumbled by 584.48% to -$281000.0 in 2025.
  • Its Deferred Taxes was -$281000.0 in Q3 2025, compared to -$151000.0 in Q2 2025 and -$209000.0 in Q1 2025.